Baltimore, MD, United States of America

Leonel Maldonado

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leonel Maldonado: Innovator in Ovarian Cancer Research

Introduction

Leonel Maldonado is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer research, particularly in the area of ovarian cancer. His innovative work focuses on identifying and ameliorating the effects of this devastating disease.

Latest Patents

Maldonado holds a patent for his invention titled "Ovarian cancer methylome." This patent provides methods and kits for identifying cells that exhibit or are predisposed to unregulated growth by detecting hypermethylation of a gene or a regulatory region in at least one gene in the cell. Additionally, the patent outlines methods for diagnosing or prognosing ovarian cancer in a subject. It also includes methods for ameliorating ovarian cancer by administering an agent that demethylates a hypermethylated gene or regulatory region.

Career Highlights

Leonel Maldonado is affiliated with The Johns Hopkins University, where he conducts his research. His work has garnered attention for its potential impact on the diagnosis and treatment of ovarian cancer. With a focus on innovative methodologies, he continues to advance the understanding of cancer biology.

Collaborations

Maldonado collaborates with esteemed colleagues, including Mohammad O Hoque and Mariana Brait. These partnerships enhance the research efforts and contribute to the development of effective cancer treatments.

Conclusion

Leonel Maldonado's contributions to ovarian cancer research exemplify the importance of innovation in medicine. His patented methods and collaborative efforts are paving the way for improved diagnosis and treatment options for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…